These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37331557)

  • 1. Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials.
    Budi HS; Farhood B
    Environ Res; 2023 Sep; 233():116432. PubMed ID: 37331557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the prostate tumor microenvironment by plant-derived natural products.
    Wu J; Ji H; Li T; Guo H; Xu H; Zhu J; Tian J; Gao M; Wang X; Zhang A
    Cell Signal; 2024 Mar; 115():111011. PubMed ID: 38104704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles.
    Qin L; Wu J
    Environ Res; 2023 Dec; 239(Pt 1):116751. PubMed ID: 37507044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles.
    Meng X; Ma F; Yu D
    Environ Res; 2024 Jan; 240(Pt 1):117362. PubMed ID: 37827371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products.
    Lafta HA; AbdulHussein AH; Al-Shalah SAJ; Alnassar YS; Mohammed NM; Akram SM; Qasim MT; Najafi M
    Curr Top Med Chem; 2023; 23(12):1104-1122. PubMed ID: 36722486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
    Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
    J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting oral tumor microenvironment for effective therapy.
    Budi HS; Farhood B
    Cancer Cell Int; 2023 May; 23(1):101. PubMed ID: 37221555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products: Potential targets of TME related long non-coding RNAs in lung cancer.
    Malla RR; Padmaraju V; Marni R; Kamal MA
    Phytomedicine; 2021 Dec; 93():153782. PubMed ID: 34627097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Products with Activity against Lung Cancer: A Review Focusing on the Tumor Microenvironment.
    Yang Y; Li N; Wang TM; Di L
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of the tumor microenvironment by curcumin.
    Fu X; He Y; Li M; Huang Z; Najafi M
    Biofactors; 2021 Nov; 47(6):914-932. PubMed ID: 34375483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
    Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
    Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mucoadhesive celecoxib-loaded cubosomal sponges: Anticancer potential and regulation of myeloid-derived suppressor cells in oral squamous cell carcinoma.
    Mabrouk AA; El-Mezayen NS; Tadros MI; El-Gazayerly ON; El-Refaie WM
    Eur J Pharm Biopharm; 2023 Jan; 182():62-80. PubMed ID: 36513316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Biology of the Tumor Microenvironment.
    Freeman JW
    Adv Exp Med Biol; 2021; 1350():91-100. PubMed ID: 34888845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting cold to hot tumors by nanoparticle-loaded drugs and products.
    Ahmad I; Altameemi KKA; Hani MM; Ali AM; Shareef HK; Hassan ZF; Alubiady MHS; Al-Abdeen SHZ; Shakier HG; Redhee AH
    Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38922537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of herbal medicines as tumor microenvironment-modulating agents.
    Park CR; Lee JS; Son CG; Lee NH
    Phytother Res; 2021 Jan; 35(1):78-94. PubMed ID: 32658314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.
    Lin G; Chen S; Mi P
    J Biomed Nanotechnol; 2018 Jul; 14(7):1189-1207. PubMed ID: 29944095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
    Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
    J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
    Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
    J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
    Xue Y; Gao S; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X; Wu R
    Expert Opin Drug Deliv; 2021 Feb; 18(2):187-203. PubMed ID: 32954856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.